Kangji Medical Holdings (HKSE:09997) EBITDA Margin % : 64.19% (As of Dec. 2023)

View and export this data going back to 2020. Start your Free Trial

What is Kangji Medical Holdings EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Kangji Medical Holdings's EBITDA for the six months ended in Dec. 2023 was HK$367 Mil. Kangji Medical Holdings's Revenue for the six months ended in Dec. 2023 was HK$571 Mil. Therefore, Kangji Medical Holdings's EBITDA margin for the quarter that ended in Dec. 2023 was 64.19%.

Kangji Medical Holdings EBITDA Margin % Historical Data

The historical data trend for Kangji Medical Holdings's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Kangji Medical Holdings EBITDA Margin % Chart

Kangji Medical Holdings Annual Data

Trend

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

EBITDA Margin %

Get a 7-Day Free Trial

79.06

62.23

79.18

74.60

67.38

Kangji Medical Holdings Semi-Annual Data
	Dec17	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
EBITDA Margin %	Get a 7-Day Free Trial							82.38	61.52	84.18	71.51	64.19

Competitive Comparison of Kangji Medical Holdings's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, Kangji Medical Holdings's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kangji Medical Holdings's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Kangji Medical Holdings's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Kangji Medical Holdings's EBITDA Margin % falls into.

Kangji Medical Holdings EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Kangji Medical Holdings's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (A: Dec. 2023 )	/	Revenue (A: Dec. 2023 )
	=	682.498	/	1012.864
	=	67.38 %

Kangji Medical Holdings's EBITDA Margin % for the quarter that ended in Dec. 2023 is calculated as

EBITDA Margin %	=	EBITDA (Q: Dec. 2023 )	/	Revenue (Q: Dec. 2023 )
	=	366.811	/	571.427
	=	64.19 %

Kangji Medical Holdings (HKSE:09997) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

Kangji Medical Holdings EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Kangji Medical Holdings's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.

Kangji Medical Holdings (HKSE:09997) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Kangji Medical Holdings Ltd (HKSE:09997) » Definitions » EBITDA Margin %

Comparable Companies

Traded in Other Exchanges

50J:Germany

Address

No. 1668 Chunjiang East Road, Tonglu Economic Development Zone, Zhejiang Province, Hangzhou, CHN

Website

https://www.kangjimedical.com

Kangji Medical Holdings Ltd is engaged in the production and sales of minimally invasive surgical instruments and accessories. The company offers a product portfolio to provide physicians and hospitals with one-shop and tailored surgical solutions for four surgical specialties OBGYN, general surgery, urology, and thoracic surgery. It manufactures and sells both disposable and reusable products. Its product portfolio includes disposable trocars, polymer ligation clips, disposable electrocoagulation forceps, and reusable trocar and forceps. It derives the majority of its revenue from Mainland China.

Kangji Medical Holdings (HKSE:09997) Headlines

No Headlines